InfectiousDiseases,USAcompanies,theBiotechcompaniesfromEurope •ErinDuffy,ChiefofRDCARB-X,USAinnovatinginAnti-Microbialresistanceresearch(BEAM) •FrancoisFranceschi,HeadofAssetEvaluationandAlliance,theBiotechnologyInnovationOrganization Development,GARDP,Switzerland(BIO),theInternationalFederationofPharmaceutical Manufact...
It also issued a warning last year for cough syrups made by four Indonesian manufacturers, PT Yarindo Farmatama, PT Universal Pharmaceutical, PT Konimex and PT AFI Pharma, that were sold domestically. The companies involved have either denied that their products have been contaminated or declined ...
Many complain that action is pointless until huge emerging market emitters like China and India agree to play their part, one executive said. SPEEDING UP Some airlines called on the EU to do more to catch up with the United States, where the Inflation Reduction Ac...
the individual companies,the Biotech companies from Europe innovating in Anti-Microbial resistance research(BEAM)Alliance,the Biotechnology Innovation Organization(BIO),the International Federation of Pharmaceutical Manufacturers and Associations(IFPMA),CARB-X,GARDP and the AMR Action Fund for par 54、tici...
used as atool in the prevention of the distribution of counterfeit pharmaceuticalproducts. It should...
“pay-to-delay” deals that have become increasingly common between branded and generic pharmaceutical companies. The FTCclaimsthat these deals are “anti-competitive” and basically amount to collusion between branded and generic companies. According to the FTC, these deals cost the American public ...
health argues, doctors or hospitals are paid for each service they provide, encouraging them to perform as many as possible and charge as much as they can. If doctors and insurance companies are part of the same business, by contrast, incentives should be aligned and overall costs should be ...
Before 2005, most pediatric ARVs were produced by innovator companies in single-component solid and liquid forms. Five 2-in1 and four 3-in-1 generic ... B Waning,E Diedrichsen,E Jambert,... - 《Bmc Pediatrics》 被引量: 76发表: 2010年 Innovative Approaches for Pharmaceutical Policy Resea...
Post Market Reporting And The Use Of Terminologies: MedDRA And WHO-DD.PSI International
1.2. This document sets out appropriate steps to assist in fulfilling the responsibilities involved in the different stages within the supply chain and to avoid the introduction of substandard and falsified products into the market. The relevant sections should be ...